semaglutide oral fda Best Options for 2026: New Wegovy Pill Approved by as Patients Compare Injectable and Compounded Access Pathways semaglutide oral brand Gets FDA

Verma Y, Gimpaya N, Tran W, et al

Semaglutide, or Ozempic, is a glucagon-like peptide-1 (GLP-1) agonist

One in eight American adults about 30 million people say they have taken a GLP-1 drug, according to a recent survey from KFF, a nonprofit group that researches health policy issues

The exact mechanism by which semaglutide promotes weight loss is not fully understood, but it is believed to involve a combination of reduced appetite, increased satiety, and improved energy expenditure

You may be a good candidate if: You are an adult with a BMI of 30 or higher, or You have a BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, high cholesterol, or heart disease

Semaglutide GLP-1 injections offer significant benefits by regulating blood sugar levels, promoting weight loss, and improving overall health outcomes for patients with type 2 diabetes and obesity